Speakers

Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

The following were speakers at the 2019 Series.

Ajan Reginald

Chief Executive Officer

Celixir

Alessio Cardinale

Head of Production

Holostem Terapie Avanzante

Alex Bloom

Vice President, Regulatory Affairs

Gyroscope Therapeutics

Alexandros Kiparissides

Assistant Professor in Biochemical Engineering

University College London

Aniz Girach

Chief Medical Officer

ProQR Therapeutics

Anke Mayer-Bartschmidt

Senior Scientist

Bayer AG

Antonio Galleu

Clinical Research Fellow

King's College London

Barney Bryson

MND Association Senior Non-Clinical Research Fellow and NIHR BRC UCL Excellence Fellow, Institute of Neurology

University College London

Bart Vaes

Associate Director, Site Leader

Regenesys

Bjørn Voldborg

Director CHO Cell Line Development

Technical University of Denmark

Caroline Odenwald

Product Manager

Progen Biotechnik GmbH

Cedric Ghevaert

Senior Lecturer, Transfusion Medicine

University of Cambridge

Chaim Lebovits

Chief Executive Officer & President

BrainStorm Cell Therapeutics

Che Connon

Professor of Tissue Engineering, Institute of Biomedicine

Newcastle University

Chris Mann

Director, Field Applications Scientists Team

MaxCyte, Inc

Christopher Spencer

Scientist II

AstraZeneca

Curtis Rambaran

Senior Director Specialty Medicine Development

Daiichi Sankyo

Darius Widera

Associate Professor in Stem Cell Biology and Regenerative Medicine

University of Reading

David Gilham

Vice President, Research & Development

Celyad

David Knop

Executive Director, Process Development

Applied Genetic Technologies Corporation

David Wright

Technical Specialist – Microscopy

Reading Scientific Services Ltd

Davide Danovi

Director, HipSci Cell Phenotyping, Centre for Stem Cells & Regenerative Medicine

King's College London

Elsa Abranches

Director

UK Stem Cell Bank

Emanuela Cuomo

Associate Director

AstraZeneca

Eric Alonzo

Senior Scientist

bluebird bio

Fabien Dorange

Head of Analytical Development

Genethon

Francesco Agostini

Biologist

AVIANO Cancer Center

Frank Thielmann

PMO & Operational Excellence Platform Leader, Biologics

Novartis

Gabriela Kozejova

Senior Scientist

GlaxoSmithKline

Gabriele Proetzel

Director, Neuroscience External Research

Takeda

Giorgio Iotti

Head of Program Leadership and Control, Rare Disease Unit

Chiesi

Helge Schnerr

Marketing Manager EMEA

Molecular Devices (UK) Ltd.

Hicham Majd

Device Project Leader - New Technologies

Novartis

Jacquelyn Awigena-Cook

Associate Director, EMEA Regulatory Intelligence & Policy

Celgene

James White

Senior Research Scientist

UCB BioPharma

Jeffrey Galvin

Chief Executive Officer & Founder

American Gene Technologies

Jennifer Smith

Senior R&D Manager, Cell Culture & Fermentation Sciences

AstraZeneca

Joerg Schwinde

Executive Director Sales and Service Support

Eppendorf AG

Johannes Moller

Clinical Research Associate

Technische Universitat Hamburg

John Johnston

Clinical Assessor

MHRA

Jonathan Orme

Team Leader UK Cell Bank

AstraZeneca

Jörg Altekrueger

Head Drug Substance Development, Basel

Novartis

Kamal Veer Saini

Senior Medical Director, Oncology

Covance, Inc.

Kamar Johnson

Cell and Gene Therapy Commercial Manager

Bio-Techne

Karen Polizzi

Reader in Biotechnology

Imperial College London

Kathrin Adlkofer

Founder and Chief Executive Officer

Cellbox Solutions

Kelvin Lee

Director and Professor

University of Delaware

Lothar Germeroth

Senior Vice President, Managing Director

Juno Therapeutics GmbH, a Celgene Company

Magda Papadaki

Associate Director, Business Strategy & Operations, Regulatory Affairs International

MSD

Manuel Carrondo

Vice President

Instituto de Biologia Experimental e Tecnologica

Marina Tarunina

Research Director

Plasticell Ltd

Mario Periera

Field Application Scientist

Horizon Discovery

Mariya Moosajee

Associate Professor

University College London

Mark Kotter

NIHR Clinician Scientist

University of Cambridge

May Sabry

Senior Research Associate

University College London

Michael O’Dwyer

Founder and Chief Security Officer

ONK Therapeutics

Mike Dyson

Chief Technology Officer

IONTAS Ltd

Min Wei

Director/Fellow

AstraZeneca

Mythili Koneru

Senior Vice President, Clinical Development

Marker Therapeutics

Nahid Turan

Chief Laboratory Officer

Coriell Institute for Medical Research

Namir Hassan

Chief Scientific Officer

Zelluna Immunotherapy

Nathan Sweeney

Senior Scientist, Cell and Gene Therapy

GlaxoSmithKline

Nicholas Forsyth

Professor of Stem Cell Biology

Keele University

Nick Leslie

Director of Research, School of Engineering and Physical Sciences

Heriot Watt University

Nicole Rickard

Senior Director, Gene Therapy Services

bluebird bio

Patrizia Ferretti

Professor of Regenerative Biology

University College London

Paul Andrews

Director

National Phenotypic Screening Centre

Paul Lammers

President & Chief Executive Officer

Triumvira Immunologics

Philipp Nold

Infield Application and Stem Cell Specialist

Eppendorf AG

Philippe Hénon

President and Chief Scientific Officer

CellProthera SAS

Qasim Rafiq

Senior Lecturer in Bioprocessing of Regenerative Medicine

University College London

Ralf Portner

Professor

Technische Universitat Hamburg

Remben Talaban

Scientific Investigator and GSK Fellow

GlaxoSmithKline

Ricardo Baptista

Director, Process & Analytical Development

Cellectis

Richard Harbottle

Head of DNA Vector Research

German Cancer Research Centre (DKFZ)

Rob Howes

Director, Discovery Biology

AstraZeneca

Robert Thomas

Professor of Cell & Gene Therapy Manufacturing

Loughborough University

Robert Vries

Chief Executive Officer

Hubrecht Organoid Technology

Samuel Fox

UK Account Manager

SCIEX Separations

Scott Ellis

Vice President of Preclinical Ophthalmology

Gyroscope Therapeutics

Selina Taferner

Scientist

Novartis

Shukry James Habib

Group Leader

King's College London

Simon Briggs

Senior Product Steward Cell & Gene Therapy Unit, C&G Technical Operations

Novartis

Sophie Escott-Morgan

Senior Scientist Design & Development

Jellagen Pty Ltd

Srinjan Basu

Group Leader in Stem Cell Science

University of Cambridge

Stefan Hauser

Head of Stem Cell Laboratory

DZNE

Stefan Przyborski

Professor of Cell Technology

Durham University

Stephan Reynier

ChiefRegulatory and Compliance Officer

Cellectis

Stephen Hyde

Professor, Molecular Therapy

University of Oxford

Suwan Jayasinghe

Professor of Bioengineering

University College London

Thomas Kretschmann

Senior Field Application Specialist

cytena GmbH

Thorsten Decker

Marketing Manager Regenerative Medicine & Cell Culture

Miltenyi Biotec

Timothy Lyden

Professor

University of Wisconsin-River Falls

Ulrich Ruemenapp

Head of Launch Preparation and Coordination

Bayer AG

Vasiliki Kalodimou

Director at Flow Cytometry - Research & Regenerative Medicine Department

IASO Maternity & Research Hospital

William Spooner

Head of Innovation

Genomics England

: Speakers

Attracting leading experts & the brightest minds in the industry to educate, inform and excite our attendees.

The following were speakers at the 2019 Series.

Copyright Oxford Global Marketing Limited. All rights reserved.